Back to Trades
Vu Quan Anh
Chief Financial OfficerCIK 0001892297
Total Volume
$708.0K
4 filings
Purchases
$104.9K
1 buy txns
Sales
$0
0 sell txns
Net Activity
$104.9K
net bought
Profile
- Filings
- 4
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Vu Quan Anh, Chief Financial Officer, has filed 4 SEC reports (2025–2026), all concentrated in Monopar Therapeutics (MNPR), totaling $708.0K in disclosed volume. Weighing $104.9K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $104.9K in Monopar Therapeutics. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Oct 2 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Exercise | $14.3K |
| Jul 2 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Exercise | $46.9K |
| Dec 29 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Buy | $104.9K |
| Dec 8 | MNPR Monopar Therapeutics | Vu Quan Anh | Chief Financial Officer | Award | $541.8K |
4 filings